ArticleVirus evolution2025
Genetic evolution of swine vesicular disease viruses circulating in Italy from 1992 to the eradication in 2015 and emergence of a recent recombinant strain.
Article in Virus evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emergence of Two Porcine Variants of Human Coxsackievirus B5 and B4 in the 20th Century That Caused Swine Vesicular Disease: A Retrospective Review.Pathogens (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Swine vesicular disease virus (SVDV) was considered endemic in Italy until 2015, when eradication was achieved. From 1992, when the most recent antigenic-genomic variant of SVDV was identified, to 2015, ~685 SVD outbreaks occurred. In order to understand the evolutionary drivers of SVDV in Italy, 152 viral strains were selected and whole-genome sequencing was performed. Comparison of the polyprotein coding region revealed a minimum pairwise identity of 85% and 98% at the nucleotide and amino acid levels, respectively, consistent with the antigenic homogeneity of the analysed strains. Phylogenetic analysis confirmed the presence of two sublineages: sublineage 1, which evolved and circulated specifically in Italy since 1995, and sublineage 2, which also includes strains circulating in both Spain and Portugal in 1993 and in Portugal during 2003. Recombination analysis revealed a breakpoint site within the 2B coding region, resulting in a recombination strain originating from viruses belonging to the two sublineages, which was dated to the beginning of 2008. This single recombination event gave rise to at least 20 recombinant strains, which circulated together with their parental strains until 2010 and from then on circulated on their own until eradication in 2015. Our data showed that, apart from the recombination event, SVDV, which has been present on Italian territory for >20 years, has not been subject to positive selective pressures that would have conferred a possible evolutionary advantage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.